Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Active-Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia

NCT03523117 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT03523117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03523117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Active-Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia
Lead sponsor
American Regent, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2019
Completion date
January 29, 2021
Enrollment
79 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia